Qingdao Vland Biotech INC. (SHA:603739)
China
· Delayed Price · Currency is CNY 13.71
+0.03 (0.22%)
Jun 6, 2025, 3:00 PM CST
SHA:603739 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 1,305 | 1,282 | 1,177 | 1,135 | 1,110 | 936.23 | Upgrade
|
Other Revenue | 38.97 | 38.97 | 21.48 | 28.42 | 40.48 | 24.02 | Upgrade
|
| Revenue | 1,344 | 1,321 | 1,199 | 1,163 | 1,151 | 960.25 | Upgrade
|
Revenue Growth (YoY) | 7.27% | 10.16% | 3.07% | 1.07% | 19.85% | 13.40% | Upgrade
|
Cost of Revenue | 741.72 | 728.42 | 648.46 | 662.86 | 620.4 | 495.66 | Upgrade
|
Gross Profit | 602.46 | 592.34 | 550.44 | 500.3 | 530.43 | 464.59 | Upgrade
|
Selling, General & Admin | 349.64 | 343.98 | 314.46 | 297.58 | 285 | 257.92 | Upgrade
|
Research & Development | 120 | 118.22 | 110.68 | 102.4 | 100.94 | 79.91 | Upgrade
|
Other Operating Expenses | 18.15 | 11.79 | 9.19 | 8.78 | 8.96 | 8.67 | Upgrade
|
Operating Expenses | 487.62 | 477.91 | 447.32 | 420.62 | 400.69 | 352.79 | Upgrade
|
Operating Income | 114.84 | 114.44 | 103.12 | 79.68 | 129.74 | 111.79 | Upgrade
|
Interest Expense | -22.49 | -21.88 | -15.22 | -7.17 | -2.12 | -1.78 | Upgrade
|
Interest & Investment Income | - | 1.53 | 8 | 3.93 | 7.91 | 6.09 | Upgrade
|
Currency Exchange Gain (Loss) | 0.47 | 0.47 | 0.58 | 3.21 | -1.18 | -2.3 | Upgrade
|
Other Non Operating Income (Expenses) | -3.38 | -2.97 | -1.62 | -8.46 | -1.88 | -0.45 | Upgrade
|
EBT Excluding Unusual Items | 89.44 | 91.58 | 94.87 | 71.18 | 132.46 | 113.35 | Upgrade
|
Gain (Loss) on Sale of Investments | 7.04 | 7.08 | 9.22 | 0.21 | 0.43 | 0.45 | Upgrade
|
Gain (Loss) on Sale of Assets | -0.39 | 0.13 | -0.25 | 0.29 | -0.05 | 0.14 | Upgrade
|
Asset Writedown | 0.09 | -0.07 | -2.75 | - | - | -0.68 | Upgrade
|
Other Unusual Items | 28.98 | 24.73 | 21.41 | 30.51 | 38.56 | 26.88 | Upgrade
|
Pretax Income | 125.16 | 123.44 | 122.5 | 102.19 | 171.4 | 140.15 | Upgrade
|
Income Tax Expense | 33.57 | 31.27 | 19.64 | 16.78 | 21.31 | 17.84 | Upgrade
|
Earnings From Continuing Operations | 91.6 | 92.17 | 102.86 | 85.41 | 150.1 | 122.3 | Upgrade
|
Minority Interest in Earnings | -32.1 | -29.53 | -22.15 | -15.57 | -17.52 | -13.33 | Upgrade
|
Net Income | 59.49 | 62.64 | 80.71 | 69.84 | 132.57 | 108.98 | Upgrade
|
Net Income to Common | 59.49 | 62.64 | 80.71 | 69.84 | 132.57 | 108.98 | Upgrade
|
Net Income Growth | -28.21% | -22.39% | 15.56% | -47.32% | 21.65% | 40.16% | Upgrade
|
Shares Outstanding (Basic) | 247 | 251 | 252 | 249 | 246 | 227 | Upgrade
|
Shares Outstanding (Diluted) | 247 | 251 | 252 | 259 | 246 | 227 | Upgrade
|
Shares Change (YoY) | -1.21% | -0.66% | -2.50% | 5.36% | 8.14% | 6.37% | Upgrade
|
EPS (Basic) | 0.24 | 0.25 | 0.32 | 0.28 | 0.54 | 0.48 | Upgrade
|
EPS (Diluted) | 0.24 | 0.25 | 0.32 | 0.27 | 0.54 | 0.48 | Upgrade
|
EPS Growth | -27.33% | -21.88% | 18.52% | -50.00% | 12.50% | 31.76% | Upgrade
|
Free Cash Flow | 87.88 | 90.69 | -62.05 | -246.72 | -404.06 | -38.83 | Upgrade
|
Free Cash Flow Per Share | 0.36 | 0.36 | -0.25 | -0.95 | -1.65 | -0.17 | Upgrade
|
Dividend Per Share | 0.100 | 0.100 | 0.100 | 0.100 | 0.160 | 0.143 | Upgrade
|
Dividend Growth | - | - | - | -37.50% | 11.97% | - | Upgrade
|
Gross Margin | 44.82% | 44.85% | 45.91% | 43.01% | 46.09% | 48.38% | Upgrade
|
Operating Margin | 8.54% | 8.66% | 8.60% | 6.85% | 11.27% | 11.64% | Upgrade
|
Profit Margin | 4.43% | 4.74% | 6.73% | 6.00% | 11.52% | 11.35% | Upgrade
|
Free Cash Flow Margin | 6.54% | 6.87% | -5.18% | -21.21% | -35.11% | -4.04% | Upgrade
|
EBITDA | 234.41 | 224.85 | 176.92 | 145.39 | 181.44 | 154.66 | Upgrade
|
EBITDA Margin | 17.44% | 17.02% | 14.76% | 12.50% | 15.77% | 16.11% | Upgrade
|
D&A For EBITDA | 119.57 | 110.41 | 73.79 | 65.71 | 51.7 | 42.87 | Upgrade
|
EBIT | 114.84 | 114.44 | 103.12 | 79.68 | 129.74 | 111.79 | Upgrade
|
EBIT Margin | 8.54% | 8.66% | 8.60% | 6.85% | 11.27% | 11.64% | Upgrade
|
Effective Tax Rate | 26.82% | 25.33% | 16.03% | 16.42% | 12.43% | 12.73% | Upgrade
|
Revenue as Reported | 1,344 | 1,321 | 1,199 | 1,163 | 1,151 | 960.25 | Upgrade
|
Advertising Expenses | - | 7.09 | 6.59 | 5.02 | 5.67 | 5.43 | Upgrade
|
Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.